Pharmacy U

News: E-Prescribing to take a big step forward in Canada with new deal

PrescribeIT® (CNW Group/OnPharm-United)

by Staff


Canada Health Infoway (Infoway) and Loblaw Companies Limited (Loblaw) have reached an agreement to advance e-prescribing in Canada.


Under the agreement, Shoppers Drug Mart, Loblaw retail pharmacies and QHR Technologies’ AccuroEMR®Canada’s largest single electronic medical record platform, will work towards connecting with PrescribeIT®, Infoway’s national e-prescribing service.


As a first step in the initiative, Shoppers Drug Mart and Loblaw will begin to roll out PrescribeIT® in pharmacies already using software that is integrated with PrescribeIT®.


“This agreement will accelerate the adoption of e-prescribing in Canada, bringing significant benefits to patients, prescribers and health care systems across the country,” said Ashesh Desai, Executive Vice President Pharmacy and Healthcare Businesses at Shoppers Drug Mart, in a news release.


“PrescribeIT® has shown tremendous momentum since it launched,” said Michael Green, President and CEO of Infoway. “This is an important expansion for PrescribeIT® and will help extend the benefits of the service more broadly.”


Loblaw will continue to operate FreedomRx, the e-prescribing and messaging platform that is currently available predominantly to Loblaw and Shoppers Drug Mart pharmacies and physicians using AccuroEMR® as their electronic medical records system.


Canada Health Infoway is working with Health Canada, the provinces and territories, and industry stakeholders to develop, operate and maintain the national e-prescribing service known as PrescribeIT®. PrescribeIT® will serve all Canadians, pharmacies and prescribers and provide safer and more effective medication management by enabling prescribers to transmit a prescription electronically between a prescriber’s electronic medical record (EMR) and the pharmacy management system (PMS) of a patient’s pharmacy of choice. PrescribeIT® will protect Canadians’ personal health information from being sold or used for commercial activities. Visit